Other headlines:Naviscan signs Korean distributor IT sales rise at Infinitt
Philips Healthcare has introduced to U.S. customers MammoDiagnost VU, a stand-alone mammography workstation that enables multivendor and multimodality image management and integration. Already available in Europe, the MammoDiagnost VU simplifies use by streamlining labor-intensive steps, automating breast tissue alignment for digital mammograms, and supporting personalized work lists.
Naviscan has signed a distribution agreement with the Hae Dong company to market and service breast-specific PET scanners in the Republic of South Korea. The first such unit capable of positron emission mammography will be installed at Seoul National University Hospital, where it will be available to physicians and researchers while awaiting Korean regulatory approval. The scanner uses PET technology to produce tomographic images that visualize breast tumors down to 2 mm, which is about the width of a grain of rice. About the size of an x-ray mammography unit, the PET scanner uses gentle breast immobilization to reduce motion artifact and improve image resolution.
Web-based IT vendor Infinitt North America is on track for a record year. The company reports that product sales in the U.S. during the first two quarters of 2009 have exceeded those of any two consecutive quarters in the firm's history. Its performance is all the more significant, according to company execs, given tight budgets at hospitals in this country and uncertainty about the future direction of healthcare. Infinitt offers web-based RIS and PACS products that support radiology, cardiology, mammography, and advanced visualization on a single common database.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
New Research Examines Socioeconomic Factors with Mammography No-Shows
April 10th 2024Patients with Medicaid or means-tested insurance were over 27 percent more likely to miss mammography appointments, and only 65 percent of women with three of more adverse social determinants of health had a mammography exam in a two-year period covering 2020 and 2021, according to new research and a report from the CDC.